$AMGN

$412.95▲ +5.0% YTD

7 SEC 13D/G filings tracked · Last updated Sep 22, 2026

Filing History

CP $412.95▲ +5.0%Sep 22, 2026 · ThinkSabio Blog

$AMGN AMGN - AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR DAZODALIBEP IN MODERATE-TO-SEVERE SYSTEMIC SJÖGREN'S DISEASE…

News

AMGN ▲ +0.1% - Amgen Inc.

CP $377.71▲ +0.1%Sep 14, 2026 · ThinkSabio Blog

$AMGN AMGN - FDA APPROVES REDUCED MONITORING TIME FOR FIRST TWO DOSES OF IMDELLTRA®…

News

AMGN ▼ -0.4% - Amgen Inc.

CP $391.27▲ -0.4%Sep 9, 2026 · ThinkSabio Blog

$AMGN AMGN - AMGEN TO PRESENT AT THE MORGAN STANLEY 24TH ANNUAL GLOBAL HEALTHCARE CONFERENCE…

News

AMGN ▼ -5.8% - Amgen Inc.

CP $411.91▲ -5.8%Sep 8, 2026 · ThinkSabio Blog

$AMGN AMGN - IMDELLTRA® IN COMBINATION WITH IMFINZI® DEMONSTRATED LANDMARK IMPROVEMENT IN OVERALL SURVIVAL IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LU…

News

AMGN ▼ -7.1% - Amgen Inc.

CP $412.56▲ -7.1%Sep 4, 2026 · ThinkSabio Blog

$AMGN down ah…

News

AMGN ▲ +1.5% - Amgen Inc.

CP $444.50▲ +1.5%Sep 2, 2026 · ThinkSabio Blog

$AMGN AMGN - AMGEN TO PRESENT AT THE 2026 WELLS FARGO HEALTHCARE CONFERENCE…

News

AMGN ▼ -0.2% - Amgen Inc.

CP $431.50▲ -0.2%Aug 31, 2026 · ThinkSabio Blog

$AMGN REDUCES RISK OF DEATH IN PATIENTS AT HIGH RISK FOR A FIRST HEART ATTACK OR STROKE…